CRKL is a critical target of Hh‐GLI2 pathway in lung adenocarcinoma

Lung adenocarcinoma (LUAD) is one of the important components of non‐small‐cell lung cancer (NSCLC) and leads to many deaths every year. During the initiation and progression of the LUAD, the Hh‐GLI2 pathway plays critical roles. Several components of this pathway have been shown to be amplified or...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoming, Hu, Yan, Yu, Bentong, Peng, Kai, Gan, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256351/
https://www.ncbi.nlm.nih.gov/pubmed/34076957
http://dx.doi.org/10.1111/jcmm.16592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256351/
https://www.ncbi.nlm.nih.gov/pubmed/34076957
http://dx.doi.org/10.1111/jcmm.16592

Ejemplares similares